Samantha McLemore Patient Capital Management
Samantha McLemore is the founder of Patient Capital Management and previously worked closely with Bill Miller on value-oriented strategies. Her firm emphasizes long-term, research-driven equity investing with a willingness to hold unconventional or out-of-favor ideas. McLemore’s portfolio is followed by investors who track the next generation of independent value managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$51M |
| 2 |
NVIDIA
NVDA
|
+$43.9M |
| 3 |
Seadrill
SDRL
|
+$10.8M |
| 4 |
Kosmos Energy
KOS
|
+$10.1M |
| 5 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$5.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Expedia Group
EXPE
|
+$29.3M |
| 2 |
Cleveland-Cliffs
CLF
|
+$21M |
| 3 |
OneMain Financial
OMF
|
+$13.6M |
| 4 |
Amazon
AMZN
|
+$13.1M |
| 5 |
Meta Platforms (Facebook)
META
|
+$10.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 31.39% |
| 2 | Financials | 23.2% |
| 3 | Communication Services | 12.05% |
| 4 | Energy | 10.1% |
| 5 | Healthcare | 9.55% |
Similar funds
Samantha McLemore's Q1 2024 Portfolio in Review
As of Q1 2024, Samantha McLemore held 45 positions worth $2.05B, up 8.8% from $1.89B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Samantha McLemore's Q1 2024 filing shows 3 new, 11 increased, 25 reduced and 3 closed positions. Its largest new stake was Biogen: 217,887 shares worth $47M. The largest sale was Expedia Group, an estimated $29.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 31% of assets, down from 34% a quarter earlier, followed by Financials and Communication Services.
- Samantha McLemore's largest Q1 2024 buy was Biogen: 217,887 shares worth $47M.
- Samantha McLemore added most to Seadrill in Q1 2024, an estimated $10.8M increase.
- Samantha McLemore's biggest Q1 2024 reduction was Expedia Group, cutting an estimated $29.3M.
- Samantha McLemore fully exited Cleveland-Cliffs in Q1 2024, selling an estimated $21M.
- Samantha McLemore's ten largest holdings make up 45% of its $2.05B portfolio in Q1 2024.
- Samantha McLemore opened 3 new positions and closed 3 in Q1 2024.
- Samantha McLemore's portfolio value rose 8.8% quarter-over-quarter to $2.05B.
Based on Patient Capital Management's 13F filing for Q1 2024, filed 15 May 2024.